Physician profile
Steve W Chang
NPI 1154501294
$1,066,633.85
in general payments reported to CMS, 2019-2025
16 companies · $77K in 2025
The $77K reported for 2025 was more than what 97% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $496K · 2020: $47K · 2021: $200K · 2022: $79K · 2023: $90K · 2024: $77K · 2025: $77K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $244K · Food and Beverage: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $243,822.67 |
| Food and Beverage | $350.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $512,830.85 | 2019-2025 | Altera, Excelsius3d Imaging System, Excelsiusgps Robotic Navigation System |
| Medtronic USA, INC. | $425,317.89 | 2019-2020 | |
| Medtronic, INC. | $113,995.88 | 2021-2023 | Unid_pass |
| Zimmer Biomet Holdings, INC. | $9,519.85 | 2019-2020 | |
| Depuy Synthes Products, INC. | $1,800.00 | 2020 | |
| Alphatec Spine, INC | $1,786.63 | 2019 | |
| Abbott Laboratories | $819.93 | 2019-2022 | |
| Carlsmed, INC. | $241.05 | 2022 | |
| Seaspine Orthopedics Corporation | $134.56 | 2020 | |
| Zimvie INC. | $85.27 | 2023 | |
| Centinel Spine, LLC | $40.78 | 2019 | |
| Highridge Medical LLC | $28.67 | 2024 | Spine-None |
| Ucb, INC. | $14.54 | 2022 | |
| Depuy Synthes Sales INC. | $12.46 | 2020 | |
| Orthofix Medical, INC. | $5.49 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$302,250.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steve Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.